Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Baxter Strengthens Home Dialysis Business In Japan

This article was originally published in PharmAsia News

Executive Summary

Baxter International's Japanese subsidiary is building up a home dialysis service in Japan

Baxter International's Japanese subsidiary is building up a home dialysis service in Japan.

The company has started to offer training workshops around the country to train in-home caregivers. The fist workshop is to be held in Tokyo at Ebara Homecare Clinic, a part of specialized home care service operator Houyu Medical Society. Baxter also plans to visit clinics to raise awareness for its in-home dialysis service among physicians. Until now, Baxter has mainly targeted medical facilities for its peritoneal dialysis solution and devices, but the company has decided to turn its focus to its home care business in order to expand the market and drive growth. (Click here for more - Japanese language)

"U.S. Baxter Supports Home Dialysis Service In Japan" - Nikkei Sangyo News (11/11/2010)

Table

View full table

Tags:
Latest Headlines

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

Biogen Sees Improving Momentum In Slow Leqembi Launch

Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative

Day One Springs Into Commercial Action With Ojemda Approval

See All
UsernamePublicRestriction

Register

SC073533

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By